… This approach was applied by the SLICC subcommittee (chaired by Graciela S. Alarcón,
MD, MPH), using the candidate set of variables to result in a preliminary data-driven …

There have been several papers published related to cancer in the rheumatic diseases,
particularly inflammatory arthritis, Sjogren's syndrome, systemic lupus erythematosus, and …

Objective To examine mortality rates in the largest systemic lupus erythematosus (SLE) cohort
ever assembled. Methods Our sample was a multisite international SLE cohort (23 centers…

Objective In systemic lupus erythematosus (SLE), disease activity and glucocorticoid (GC)
exposure are known to contribute to irreversible organ damage. We aimed to examine the …

Individuals with systemic lupus erythematosus (SLE) have an increased susceptibility to
certain types of cancer. Of particular concern are haematologic malignancies, specifically non-…

Background and aims We studied damage accrual and factors determining development
and progression of damage in an international cohort of systemic lupus erythematosus (SLE) …

Objective There is increasing evidence in support of an association between systemic lupus
erythematosus (SLE) and malignancy, but in earlier studies the association could not be …

… centre’s institutional … IV-S (27 A, 16 A/C and 7 C) and 77 were Class IV-G (50 A, 15 A/C and
12 C). For all of the 377 biopsies, the mean (s.d.) activity index was 4.3 (3.3) and the mean (s.…

… Factors that were considered included onset of NP event(s) prior to the enrollment window,
presence of concurrent non-SLE factor(s) that were identified as part of the ACR definitions of …

Objectives. To assess the risk of severe infections associated with the use of traditional
disease-modifying anti-rheumatic drugs (DMARDs) and glucocorticoid agents in rheumatoid …